Examples
| Generic Name | Brand Name |
|---|
| peginterferon alfa-2a | Pegasys |
| peginterferon alfa-2b | Peg-Intron |
How It Works
Peginterferons are a complex family of
proteins that are produced by the body and that help
you fight disease. They also can stop viruses from multiplying and damaging the
body.
Peginterferon is given as a shot once a week to treat long-term
(chronic)
hepatitis C.
Peginterferons most often are combined with another medicine called
ribavirin for the best results. Occasionally they are given without ribavirin.
A person may not be given ribavirin if he or she has
anemia, a heart problem, or a kidney problem.
Why It Is Used
Peginterferons may be used to treat chronic hepatitis C if you
have:
- Liver
enzyme levels that remain elevated for more than 6
months. This indicates that you probably have long-term, chronic liver
inflammation caused by the hepatitis C
virus.
- Detectable levels of hepatitis C
virus in your blood.
- Evidence of
significant liver damage. This is detected with a
liver biopsy.
How Well It Works
For many years, combination therapy with interferon and ribavirin
was the standard treatment. Now, the combination of peginterferon and ribavirin
is considered the best treatment for hepatitis C.
How well treatment works is measured by whether you still have the
virus in your blood 6 months after treatment. If you are treated with
interferons alone (interferon monotherapy), treatment generally works 10% to
20% of the time.1 When interferons or peginterferons
are combined with ribavirin, treatment works anywhere from 40% to 80% of the
time.1 Treatment is more likely to work if:
- You have a low level of the hepatitis C virus
in your blood when treatment starts.
- You have
genotype 2 or 3.
- You have a small amount
of liver damage when treatment starts.
- You do not have
HIV.
- You do not abuse alcohol.
Side Effects
Side effects from interferon, peginterferon, and ribavirin are
common. If your side effects are severe, you may need to stop treatment. About
10% to 25% of people stop their treatments because they feel too sick to finish
them.2 Some side effects may decrease as treatment
continues.
Common side effects of combination antiviral therapy
include:
- Fatigue, headache, muscle and joint aches,
fever, or chills.
- Nausea, loss of appetite, or weight
loss.
- Irritability,
insomnia, or confusion.
- Depression.
- Thyroid
problems.
- Hair loss or skin rash.
- Low levels of
red cells,
white cells, and
platelets in your blood.
If you develop anemia as a result of taking ribavirin, your doctor
may prescribe a medicine called erythropoietin to help your body create more
red blood cells.
Most side effects go away when you stop taking the
medicines.
See Drug Reference for a full list of side effects. (Drug Reference
is not available in all systems.)
What To Think About
Treatment for chronic hepatitis C lowers the chance of liver
cancer.3
You will need regular follow-up visits with a liver specialist
during treatment. The specialist will order blood tests to check your liver
enzyme levels and to see whether the virus is still multiplying.
A person with normal or slightly elevated liver enzyme levels but
whose liver biopsy shows little or no liver damage may choose not to have
antiviral treatment. Instead, a doctor can monitor these conditions with
periodic
liver function tests and a liver biopsy every 3 to 5
years.
Even if the initial treatment does not eliminate the virus, your
doctor may advise you to continue antiviral treatment, because it may reduce
liver inflammation. For some people with significant liver damage, antiviral
therapy may slow the progression of liver damage or make
liver cancer less likely. If you already have
cirrhosis, some studies show that antiviral therapy
can help you live longer.4
If it is possible that you are pregnant, you will need a pregnancy
test. Women and men who are taking ribavirin need to avoid getting pregnant or
fathering a child, because this medicine can damage a developing fetus. Women
who could become pregnant and their partners must use two reliable forms of
birth control during treatment and for 6 months after treatment, to avoid
pregnancy.
Only a few clinical trials have tested antiviral medicines in
children. Results suggest that they work about as well in children as in
adults. Combination therapy using interferon and ribavirin is now approved by
the U.S. Food and Drug Administration for use in children ages 3 to 17
years.
If you are
obese or have
diabetes, you may need to delay treatment to get your
weight or blood sugar under control.
If you have tried interferon in the past and did not get good
results, talk to a doctor who is a liver specialist (hepatologist). The hepatologist will be able to tell
you about newer combinations of peginterferon with ribavirin or new,
experimental treatments.
The long-term health effects of combination antiviral therapy are
not known at this time.
Complete the
new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.